Clinical Trial Update: Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Seroquel XR as add-on therapy for acute bipolar mania with partial response; the trial was terminated and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Bipolar Mania | Phase 4 | Status: TERMINATED | Results posted: 2012-04-10